Status:
COMPLETED
The Analgesic Effect of Intrathecal Hydromorphone Injection on Spinal Anesthesia
Lead Sponsor:
Korea University Anam Hospital
Collaborating Sponsors:
Korea University
Conditions:
Pain Measurement
Visual Analog Pain Scale
Eligibility:
All Genders
18-72 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the adequate dose of intrathecal hydromorphone injection for postoperative pain relief after knee arthroscopic surgery.
Detailed Description
Sixty patients who were undergoing unilateral knee arthroscopy randomly received unilateral spinal anesthesia with 0.5% hyperbaric bupivacaine 6 mg combined with normal saline 0.05 mL or hydromorphone...
Eligibility Criteria
Inclusion
- ASA class I-II (age range: 18-72 years)
- Informed consent obtained patients
Exclusion
- The exclusion criteria included evidence of neurological or neuromuscular disease, respiratory or cardiac disease, diabetes mellitus or peripheral neuropathy, as well as those patients who were receiving chronic analgesic therapy or who had infection at the intended site of spinal needle insertion or who had hypersensitivity to amide local anesthetics or opioids
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2010
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01172782
Start Date
July 1 2009
End Date
July 1 2010
Last Update
June 27 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.